Dr. Paul Brandon Lamb, MD

Dr. Lamb practices at Digestive Health Specialists in Dothan, Alabama.

Dr. Lamb's NPI, 1386769404, was assigned on March 20, 2007. Dr. Lamb graduated from University of South Alabama College of Medicine in 2005. Dr. Lamb holds Alabama license MD28030.

Dr. Lamb's primary practice is Digestive Health Specialists, at 480 Honeysuckle Road, Dothan, AL 36305. The practice phone is (334) 836-1212.

Dr. Lamb's primary practice is Digestive Health Specialists in Dothan, Alabama. Dr. Lamb is also affiliated with Southeast Health Medical Center. The medical group on file is Digestive Health Specialists. Dmand AI also links Dr. Lamb to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Lamb's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lamb practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lamb's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Lamb's licenses on file in 2 states: Alabama and North Dakota.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroenteritis among the conditions Dr. Lamb treats.

CMS data shows 21,639 Medicare services from Dr. Lamb across 27 procedure codes in 2024, for 711 Medicare patients. Medicare paid $450,774 for them.

CMS counts 711 Medicare patients who saw Dr. Lamb in 2024. The largest group is 65 to 74, with 313 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lamb's median patient age at 62, with 56% women.

In 2024, Dr. Lamb wrote 4,184 Medicare Part D claims for 988 patients. 81% of them were for generic drugs. CMS names the drug for 3,895 of them, across 48 drugs with 11 or more claims each, at $1,334,660 in total drug cost. In 2023, CMS named 3,463 claims across 50 drugs.

Dr. Lamb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 242 procedures of colonoscopy by Dr. Lamb, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Lamb, published from 2013 to 2014. 2013 was the busiest year, with 2. Dr. Lamb's most frequent co-authors are Yang Liu, MD, Daniel Francis Battafarano, DO and Allyson Elizabeth Cochet, MD.

Dmand AI links Dr. Lamb to 6 clinical trials. 3 are still active or recruiting. Conditions studied include Colitis, Ulcerative, Colitis and Crohn Disease. Eli Lilly and Company sponsors the most, 5. Open Payments lists research payments to Dr. Lamb that name 4 trials.

CMS Open Payments shows 863 general payments to Dr. Lamb from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. Allergan Inc. paid the most, $91,773. It also lists 10 research payments totaling $10,195 from 2018 to 2021, naming 4 clinical trials.

Dr. Lamb graduated from University of South Alabama College of Medicine in 2005.

Dr. Lamb is in network with 18 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.